Key result
Higher hemoglobin-to-creatinine ratio linked to reduced 180-day readmission or mortality in older HF patients.
Why the study?
Older patients with heart failure have poor post-discharge prognoses, highlighting the need for risk stratification to improve out-of-hospital management.
Does a higher serum hemoglobin-to-creatinine ratio (HCR) predict a reduced risk of post-discharge readmission or mortality in older patients with heart failure?
Cohort
No
Does a higher serum hemoglobin-to-creatinine ratio (HCR) predict a reduced risk of post-discharge readmission or mortality in older patients with heart failure?
p-value: p=<0.001
A higher serum hemoglobin-to-creatinine ratio is associated with a lower risk of 180-day readmission or mortality in older patients with heart failure, suggesting its utility as a simple prognostic marker.
Should not yet change risk stratification in older HF; hypothesis-generating for HCR as a prognostic marker pending prospective validation.
Background: Older patients with heart failure (HF) experience poor prognoses after hospital discharge, underscoring the importance of risk stratification for improving out-of-hospital management. Therefore, this study aimed to investigate the association between a composite index of anemia and renal impairment, defined as the serum hemoglobin-to-creatinine ratio (HCR), and post-discharge readmission or mortality in older patients with HF. Methods: Data were obtained from the Zigong Fourth People's Hospital. HF was diagnosed in accordance with the 2016 European Society of Cardiology guidelines. The HCR was employed, while the outcome was a composite of readmission or mortality assessed at 180 and 90 days after discharge. The association between the HCR and outcomes was analyzed using Cox proportional hazards models, with robustness evaluated through subgroup and sensitivity analyses. Results: for trend < 0.001) compared with the lowest tertile. Similar associations were observed for the 90-day composite outcome. The stability of these associations was confirmed through subgroup and sensitivity analyses. Conclusions: A higher HCR is independently associated with a reduced risk of readmission or mortality within 180 days of discharge in older patients with HF. The HCR may serve as a useful prognostic marker for risk stratification in this population.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted a cohort in Heart failure. Serum hemoglobin-to-creatinine ratio (HCR) vs. Lowest tertile of HCR was evaluated on Composite of readmission or mortality assessed at 180 and 90 days after discharge (p=<0.001). A higher serum hemoglobin-to-creatinine ratio was independently associated with a reduced risk of readmission or mortality within 180 days of discharge in older patients with heart failure (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: